Breast cancer liver metastasis: current and future treatment approaches
NS Rashid, JM Grible, CV Clevenger… - Clinical & experimental …, 2021 - Springer
Nearly all fatalities arising from breast tumors are attributable to distant metastases. Breast
cancer liver metastasis (BCLM) is associated with poor prognoses, with the median survival …
cancer liver metastasis (BCLM) is associated with poor prognoses, with the median survival …
[HTML][HTML] Pancreatic cancer: challenges and opportunities in locoregional therapies
Simple Summary Pancreatic cancer is a serious ongoing global health burden, with an
overall 5-year survival rate of less than 5%. One major hurdle in the treatment of this disease …
overall 5-year survival rate of less than 5%. One major hurdle in the treatment of this disease …
A single-center retrospective analysis of periprocedural variables affecting local tumor progression after radiofrequency ablation of colorectal cancer liver metastases
Background Local tumor progression (LTP) is associated with poorer survival in patients
undergoing radiofrequency ablation (RFA) for colorectal liver metastasis (CLM). An …
undergoing radiofrequency ablation (RFA) for colorectal liver metastasis (CLM). An …
Incomplete radiofrequency ablation induced chemoresistance by up-regulating heat shock protein 70 in hepatocellular carcinoma
F Wang, C Xu, G Li, P Lv, J Gu - Experimental Cell Research, 2021 - Elsevier
Radiofrequency ablation (RFA) is a common minimally invasive treatment for hepatocellular
carcinoma (HCC). Incomplete RFA (iRFA) due to the sub-lethal heat shock challenge of …
carcinoma (HCC). Incomplete RFA (iRFA) due to the sub-lethal heat shock challenge of …
[HTML][HTML] FRA-1: A key factor regulating signal transduction of tumor cells and a potential target molecule for tumor therapy
F Zeng, J He, X Jin, Q Liao, Z Chen, H Peng… - Biomedicine & …, 2022 - Elsevier
Abstract Fos-related antigen-1 (FRA-1) is a member of activator protein-1 (AP-1)
transcription factor superfamily, and FRA-1 is highly expressed in colon cancer, breast …
transcription factor superfamily, and FRA-1 is highly expressed in colon cancer, breast …
[HTML][HTML] Xanthohumol targets the ERK1/2‑Fra1 signaling axis to reduce cyclin D1 expression and inhibit non‑small cell lung cancer
F Gao, M Li, L Zhou, W Liu, H Zuo… - Oncology …, 2020 - spandidos-publications.com
High expression of cyclin D1 has a crucial role in the maintenance of unlimited cell growth in
human cancer cells. The present study indicated that cyclin D1 was overexpressed in …
human cancer cells. The present study indicated that cyclin D1 was overexpressed in …
Periprocedural risk factors for incomplete radiofrequency ablation of liver metastases from colorectal cancer: A single-center retrospective analysis
H Fan, X Wang, J Qu, W Lu, Z Pang… - International journal …, 2021 - Taylor & Francis
Objective To explore independent risk factors for incomplete radiofrequency ablation (iRFA)
of colorectal cancer liver metastases (CRLM) and evaluate adverse outcomes following …
of colorectal cancer liver metastases (CRLM) and evaluate adverse outcomes following …
Distinct effects of heat shock temperatures on mitotic progression by influencing the spindle assembly checkpoint
S Ota, Y Tanaka, R Yasutake, Y Ikeda, R Yuki… - Experimental Cell …, 2023 - Elsevier
Heat shock is a physiological and environmental stress that leads to the denaturation and
inactivation of cellular proteins and is used in hyperthermia cancer therapy. Previously, we …
inactivation of cellular proteins and is used in hyperthermia cancer therapy. Previously, we …
[HTML][HTML] Comparison of percutaneous radiofrequency ablation for subcapsular and non-subcapsular colorectal cancer liver metastases
H Fan, X Wang, J Qu, W Lu, S Xu, X Wu, J Xia… - Frontiers in …, 2021 - frontiersin.org
Purpose: To evaluate the efficacy and safety of percutaneous radiofrequency ablation (RFA)
for subcapsular colorectal cancer liver metastases (CLMs). Materials and methods: With the …
for subcapsular colorectal cancer liver metastases (CLMs). Materials and methods: With the …
[HTML][HTML] Specific inhibitor of matrix metalloproteinase decreases tumor invasiveness after radiofrequency ablation in liver tumor animal model
AN Jiang, JT Liu, K Zhao, H Wu, S Wang, K Yan… - Frontiers in …, 2020 - frontiersin.org
Objective To determine whether the specific inhibitor of matrix metalloproteinase (MMP)—
batimastat (BB-94)—could decrease the progression of liver tumor after radiofrequency …
batimastat (BB-94)—could decrease the progression of liver tumor after radiofrequency …